Erythroid but not cytogenetic response in a case with 5q- syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?

MeSH terms

• Aged
• Anemia, Macrocytic / complications
• Anemia, Macrocytic / genetics*
• Benzoates / therapeutic use*
• Chromosome Deletion
• Chromosomes, Human, Pair 5 / drug effects
• Chromosomes, Human, Pair 5 / genetics
• Deferasirox
• Erythroid Cells / drug effects*
• Erythropoiesis / drug effects*
• Female
• Humans
• Immunologic Factors / adverse effects
• Immunologic Factors / therapeutic use*
• Lenalidomide
• Myelodysplastic Syndromes / complications
• Myelodysplastic Syndromes / drug therapy
• Myelodysplastic Syndromes / genetics
• Thalidomide / adverse effects
• Thalidomide / analogs & derivatives*
• Thalidomide / therapeutic use
• Treatment Outcome
• Triazoles / therapeutic use*